Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Robert Beck

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 2, 2016
Overtreatment and Cost-Effectiveness of the See-and-Treat Strategy for Managing Cervical PrecancerVan T Nghiem, Kalatu R Davies, J Robert Beck, et al.
Diabetes Care|April 28, 2004
Cost-effectiveness analysis of telemedicine to evaluate diabetic retinopathy in a prison populationNoriaki Aoki, Kim Dunn, Tsuguya Fukui, et al.
Journal of Biomedical Informatics|June 6, 2009
Integration of prostate cancer clinical data using an ontologyHua Min, Frank J Manion, Elizabeth Goralczyk, et al.
International Journal of Medical Informatics|August 24, 2001
Feature mining and predictive model construction from severe trauma patient's dataJ Demsar, B Zupan, N Aoki, et al.
Journal of Health Communication|August 17, 2011
Exploring the potential of Web 2.0 to address health disparitiesM Chris Gibbons, Linda Fleisher, Rachel E Slamon, et al.
Medical Care|May 25, 2013
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score WorkSteven R Austin, Yu-Ning Wong, Robert G Uzzo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Reevaluating the Evidence for Intensive Postoperative Extracolonic Surveillance for Nonmetastatic Colorectal CancerJonah Popp, David S Weinberg, Eva Enns, et al.
Cancer|March 25, 2009
Cost implications of new treatments for advanced colorectal cancerYu-Ning Wong, Neal J Meropol, William Speier, et al.
International Journal of Radiation Oncology, Biology, Physics|August 20, 2005
Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10)Andre Konski, Eric Sherman, Murray Krahn, et al.
Journal of Oncology Practice|July 24, 2014
Oncologists' response to new data regarding the use of epidermal growth factor receptor inhibitors in colorectal cancerEfrat Dotan, Tianyu Li, Michael J Hall, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 2, 2016
Overtreatment and Cost-Effectiveness of the See-and-Treat Strategy for Managing Cervical PrecancerVan T Nghiem, Kalatu R Davies, J Robert Beck, et al.
Diabetes Care|April 28, 2004
Cost-effectiveness analysis of telemedicine to evaluate diabetic retinopathy in a prison populationNoriaki Aoki, Kim Dunn, Tsuguya Fukui, et al.
Journal of Biomedical Informatics|June 6, 2009
Integration of prostate cancer clinical data using an ontologyHua Min, Frank J Manion, Elizabeth Goralczyk, et al.
International Journal of Medical Informatics|August 24, 2001
Feature mining and predictive model construction from severe trauma patient's dataJ Demsar, B Zupan, N Aoki, et al.
Journal of Health Communication|August 17, 2011
Exploring the potential of Web 2.0 to address health disparitiesM Chris Gibbons, Linda Fleisher, Rachel E Slamon, et al.
Medical Care|May 25, 2013
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score WorkSteven R Austin, Yu-Ning Wong, Robert G Uzzo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Reevaluating the Evidence for Intensive Postoperative Extracolonic Surveillance for Nonmetastatic Colorectal CancerJonah Popp, David S Weinberg, Eva Enns, et al.
Cancer|March 25, 2009
Cost implications of new treatments for advanced colorectal cancerYu-Ning Wong, Neal J Meropol, William Speier, et al.
International Journal of Radiation Oncology, Biology, Physics|August 20, 2005
Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10)Andre Konski, Eric Sherman, Murray Krahn, et al.
Journal of Oncology Practice|July 24, 2014
Oncologists' response to new data regarding the use of epidermal growth factor receptor inhibitors in colorectal cancerEfrat Dotan, Tianyu Li, Michael J Hall, et al.
Pageof 4